Arcus Biosciences, Inc. — Director's Dealing 2018

Jun 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2018-06-08

Reporting Person: Jarrett Jennifer (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-08	Stock Option (right to buy)	$16.95	A	161114	Acquired	2028-06-07	Common Stock (161114)	Direct

Footnotes

F1: 1/48th of the shares of common stock subject to the option vest on the last day of the calendar month after May 31, 2018, and 1/48th of the shares subject to the option vest on the last day of the 47 calendar months immediately thereafter, subject to the Reporting Person's continued service to the Company.